Spine

Top Story

$1.4 billion settlement against opioid manufacturer puts spotlight on generic drugs, treatment gaps

$1.4 billion settlement against opioid manufacturer puts spotlight on generic drugs, treatment gaps
July 23, 2019
FDA News

FDA approves first generic alternatives to Lyrica

July 22, 2019
The FDA has approved several generic versions of pregabalin for the treatment of patients with neuropathic pain related to diabetic neuropathy, postherpetic neuralgia…

Centinel Spine receives IDE approval for cervical total disc replacement devices

July 19, 2019
Centinel Spine LLC announced it received investigational device approval from the FDA to begin a two-level clinical trial for its prodisc C anterior cervical total disc…
Perspective

CMS proposes to cover acupuncture for low back pain

July 18, 2019
CMS announced in a press release that it has proposed to cover acupuncture as a possible alternative treatment to opioid use for Medicare beneficiaries with chronic low…
More Headlines »
Feature Article

Impact of Race Subgroups on the Assessment of Vitamin D Status in Adolescent Idiopathic Scoliosis

Orthopedics, May/June 2019, Volume 42 Issue 3
The authors' main objective was to demonstrate the confounding effect of combining subgroup data, specifically race, on…
More »
CME CE ABIM MOC ABP MOC

X-linked Hypophosphatemia: Integrating New Evidence to Optimize Diagnosis and Treatment

This activity is supported by an educational grant from Ultragenyx.

X-linked hypophosphatemia (XLH) is a rare hereditary form of non-nutritional rickets that does not respond to vitamin D…
More »
Video
Meeting News

VIDEO: Surgeons need to consider their well-being on behalf of patients

March 13, 2019
More »